Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption

NCT02788175 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

NIH

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: Entyvio (Vedolizumab)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)